These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SEN virus infection and its relationship to transfusion-associated hepatitis. Umemura T, Yeo AE, Sottini A, Moratto D, Tanaka Y, Wang RY, Shih JW, Donahue P, Primi D, Alter HJ. Hepatology; 2001 May; 33(5):1303-11. PubMed ID: 11343260 [Abstract] [Full Text] [Related]
3. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV. Minz M, Sharma A, Das A, Chawla Y. Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242 [Abstract] [Full Text] [Related]
4. Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection. Hu YW, Al-Moslih MI, Al Ali MT, Uzicanin S, Perkins H, Yi QL, Rahimi Khameneh S, Wu J, Brown EG. J Med Virol; 2008 Feb; 80(2):365-71. PubMed ID: 18098140 [Abstract] [Full Text] [Related]
5. SEN virus infection does not affect the progression of non-A to -E liver disease. Mikuni M, Moriyama M, Tanaka N, Abe K, Arakawa Y. J Med Virol; 2002 Aug; 67(4):624-9. PubMed ID: 12116015 [Abstract] [Full Text] [Related]
7. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus]. Wu CH, Xu XY, Tian GS, Yu YY. Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):390-3. PubMed ID: 16677548 [Abstract] [Full Text] [Related]
9. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern? Berenguer M, Aguilera V, Prieto M, Carrasco D, Rayón M, San Juan F, Landaverde C, Mir J, Berenguer J. Liver Transpl; 2003 Nov 14; 9(11):1152-8. PubMed ID: 14586875 [Abstract] [Full Text] [Related]